ethyl 2-[3-[6-[3-(2-oxopyrrolidin-1-yl)propylamino]-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]propanoylamino]propanoate

C20H29N7O4 — CID 20957506

IUPACethyl 2-[3-[6-[3-(2-oxopyrrolidin-1-yl)propylamino]-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]propanoylamino]propanoate
SMILESCCOC(=O)C(C)NC(=O)CCc1nnc2ccc(NCCCN3CCCC3=O)nn12
InChIInChI=1S/C20H29N7O4/c1-3-31-20(30)14(2)22-18(28)10-9-17-24-23-16-8-7-15(25-27(16)17)21-11-5-13-26-12-4-6-19(26)29/h7-8,14H,3-6,9-13H2,1-2H3,(H,21,25)(H,22,28)
InChIKeyDUHZVYAQDXTOGZ-UHFFFAOYSA-N
MW431.50 g/mol
LogP0.55
Rot. Bonds11

About ethyl 2-[3-[6-[3-(2-oxopyrrolidin-1-yl)propylamino]-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]propanoylamino]propanoate

ethyl 2-[3-[6-[3-(2-oxopyrrolidin-1-yl)propylamino]-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]propanoylamino]propanoate (PubChem CID 20957506) has the molecular formula C20H29N7O4 and a molecular weight of 431.50 g/mol. Its IUPAC name is ethyl 2-[3-[6-[3-(2-oxopyrrolidin-1-yl)propylamino]-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]propanoylamino]propanoate.

Molecular Properties

Compound Nameethyl 2-[3-[6-[3-(2-oxopyrrolidin-1-yl)propylamino]-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]propanoylamino]propanoate
PubChem CID20957506
Molecular FormulaC20H29N7O4
Molecular Weight431.50 g/mol
Exact Mass431.23
IUPAC Nameethyl 2-[3-[6-[3-(2-oxopyrrolidin-1-yl)propylamino]-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]propanoylamino]propanoate
SMILESCCOC(=O)C(C)NC(=O)CCc1nnc2ccc(NCCCN3CCCC3=O)nn12
InChIInChI=1S/C20H29N7O4/c1-3-31-20(30)14(2)22-18(28)10-9-17-24-23-16-8-7-15(25-27(16)17)21-11-5-13-26-12-4-6-19(26)29/h7-8,14H,3-6,9-13H2,1-2H3,(H,21,25)(H,22,28)
InChIKeyDUHZVYAQDXTOGZ-UHFFFAOYSA-N
XLogP0.55
TPSA130.82 Ų
H-Bond Donors2
H-Bond Acceptors9
Rotatable Bonds11
Heavy Atoms31
Complexity

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500431.50
LogP ≤ 50.55
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 109

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}

Analyze ethyl 2-[3-[6-[3-(2-oxopyrrolidin-1-yl)propylamino]-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]propanoylamino]propanoate with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of ethyl 2-[3-[6-[3-(2-oxopyrrolidin-1-yl)propylamino]-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]propanoylamino]propanoate?
The IUPAC name of ethyl 2-[3-[6-[3-(2-oxopyrrolidin-1-yl)propylamino]-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]propanoylamino]propanoate (CID 20957506) is ethyl 2-[3-[6-[3-(2-oxopyrrolidin-1-yl)propylamino]-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]propanoylamino]propanoate.
What is the SMILES notation for ethyl 2-[3-[6-[3-(2-oxopyrrolidin-1-yl)propylamino]-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]propanoylamino]propanoate?
The canonical SMILES for ethyl 2-[3-[6-[3-(2-oxopyrrolidin-1-yl)propylamino]-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]propanoylamino]propanoate is CCOC(=O)C(C)NC(=O)CCc1nnc2ccc(NCCCN3CCCC3=O)nn12.
What is the InChIKey of ethyl 2-[3-[6-[3-(2-oxopyrrolidin-1-yl)propylamino]-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]propanoylamino]propanoate?
The InChIKey is DUHZVYAQDXTOGZ-UHFFFAOYSA-N. The full InChI is InChI=1S/C20H29N7O4/c1-3-31-20(30)14(2)22-18(28)10-9-17-24-23-16-8-7-15(25-27(16)17)21-11-5-13-26-12-4-6-19(26)29/h7-8,14H,3-6,9-13H2,1-2H3,(H,21,25)(H,22,28).
What are the key properties of ethyl 2-[3-[6-[3-(2-oxopyrrolidin-1-yl)propylamino]-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]propanoylamino]propanoate?
ethyl 2-[3-[6-[3-(2-oxopyrrolidin-1-yl)propylamino]-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]propanoylamino]propanoate has a molecular weight of 431.50 g/mol, XLogP of 0.55, 11 rotatable bonds, 2 hydrogen bond donors, and 9 hydrogen bond acceptors.
Where does this data come from?
All data for ethyl 2-[3-[6-[3-(2-oxopyrrolidin-1-yl)propylamino]-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]propanoylamino]propanoate is sourced from PubChem (CID 20957506), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).